customer engagement

AI as Business Leverage in Pharma & Life Sciences

If there was an AI solution in the Life Sciences field, able to represent a real opportunity in terms of Customer Engagement and Digital Transformation, and if some of the most important players in the industry already had it, would you like to have the opportunity to listen to them?    This and other trend …

AI as Business Leverage in Pharma & Life Sciences Read More »

Experts discuss the field force’s customer-centric future

The ways in which HCPs prefer to engage with pharma has been changing for quite some time, and the digital transformation brought by COVID has dramatically accelerated that. In a recent pharmaphorum webinar, in partnership with Axtria, commercialisation experts from across the industry discussed how the right field force training and execution in combination with …

Experts discuss the field force’s customer-centric future Read More »

Reality Check | Is Your Current Customer Engagement Solution the Best Choice for All Markets?

Do your sales reps drive a Ferrari? Probably not. Would they like one if you offered it to them? Probably. Once they were used to driving around in a Ferrari, how easy do you think it would be to convince them to give it back? Nearly impossible. They would argue it is the only way to get to their appointments on time. Nothing else would measure up. So why would …

Reality Check | Is Your Current Customer Engagement Solution the Best Choice for All Markets? Read More »

Omnichannel customer-centric teams and the future of pharma CRM

If pharma companies are to live up to their decades-old patient-centric promises then marketing budgets need to move from brands and franchises to omnichannel customer-centric teams, according to one digital transformation leader. The industry is making some progress with this, but it’s not enough, says Edwin Erckens, who was until recently chief information officer within …

Omnichannel customer-centric teams and the future of pharma CRM Read More »

Nine for 2021: Addressing the pandemic legacy

In this second ‘Nine for 2021‘ article, IQVIA’s Sarah Rickwood looks at four issues which will directly impact pharma in 2021: the permanent changes in customer engagement models, the implications of a geographic re-balancing towards the East, CNS as the new value growth area for the 2020s, and the new biologics environment as biosimilars accelerate. …

Nine for 2021: Addressing the pandemic legacy Read More »

Time to change the channel? The future for customer engagement models

Sarah Rickwood delves into IQVIA data to find out exactly how pharma’s HCP engagement has changed over COVID-19, and what the channel mix might look like after the pandemic. The pandemic has triggered a change in how pharmaceutical companies are engaging with healthcare professionals. With in-person visits drastically reduced, pharma has been challenged to find …

Time to change the channel? The future for customer engagement models Read More »